© 2020 MJH Life Sciences and HCPLive. All rights reserved.
June 23, 2020
A new study found newly diagnosed type 2 diabetics who develop heart failure had the highest risk of death versus patients with other CVDs or chronic kidney disease.
June 22, 2020
The COVID-19 pandemic accelerated plans to make changes within their electronic health record system for a trio of Saint Louis University doctors.
June 20, 2020
New research from ARVO 2020 suggests patients with diabetic eye disease can still experiences losses in visual acuity, even with glycemic control.
June 19, 2020
New research suggests signs a person may be more susceptible to type 2 diabetes later in life are visible in children as young as 8 years old.
The FDA's approval of insulin lispro-aabc injection is based on the results of 2 phase 3 trials—PRONTO-T1D and PRONTO-T2D.
June 17, 2020
Women with recent gestational diabetes who use the intervention see less retention of weight than those who do not use the intervention.
An analysis of data from 5 PIONEER trials is shedding new light on the impact of oral semaglutide based on background glucose-lowering therapy.
The drug also reduced the risk of myocardial infarction and stroke.
Taking testosterone while enrolled in a lifestyle program reduces glucose levels and risk of type 2 diabetes.
Discussing how advances in care and therapeutic agents have impacted the management of diabetes in 2020.